Cornerstone Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
DLA
OIAM
YIH
CNB
COPPSERS
PFSRSONJ
MIM
LAI
Cornerstone Wealth Management's MRNA Position: Q2 2026 in Review
Cornerstone Wealth Management opened a new position in Moderna (MRNA) in Q2 2026: 3,793 shares worth $266K. The stake represents 0.01% of the portfolio and ranks #643 among its holdings. This is a return to the name: Cornerstone Wealth Management previously reported a position in MRNA as recently as Q1 2024.
Cornerstone Wealth Management first reported a position in MRNA in Q1 2021 and has held it in 13 quarters since. The position peaked at $1.33M in Q3 2021. 154 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Cornerstone Wealth Management held 3,793 shares of Moderna worth $266K as of Q2 2026.
- Moderna was a new Cornerstone Wealth Management position in Q2 2026.
- Moderna made up 0.01% of Cornerstone Wealth Management's portfolio in Q2 2026, its #643 holding.
- Cornerstone Wealth Management first reported a position in Moderna in Q1 2021 and has held it in 13 quarters since.
- Cornerstone Wealth Management's Moderna position peaked at $1.33M in Q3 2021.
- 154 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.